National Institutes of Health · ABD

Discovery Gateway to Reproductive Health Innovation

Ön duyuru — 24 Temmuz 2027 tarihinde açılması bekleniyor

Bu bir ön duyurudur: fon sağlayıcı fırsatı duyurdu ancak henüz başvuruya açık değil; yayınlanması yaklaşık 24 Temmuz 2027 tarihinde bekleniyor, tahmini son tarih 1 Ekim 2027. Uygun başvuru sahibi türleri (kaynakta): Native American tribal governments (Federally recognized), State governments, Special district governments ve 12 diğer.

Son başvuru: Tahmini 1 Ekim 2027 (henüz kesin değil)
Açılış: 24 Temmuz 2027
Hibe tutarı: Belirtilmemiş — resmi çağrıya bakın
Destek oranı: Zorunlu eş finansman belirtilmemiş; destek oranı belirtilmemiş
Eş finansman: Gerekli değil
Olası başvuru sahipleri: Kamu kurumları, Üniversiteler ve araştırma, KOBİ’ler / girişimler, Şirketler, Kâr amacı gütmeyenler Kaynak kategorilerinden veya program kurallarından; uygunluğa çağrı karar verir.
Fon sağlayıcı: National Institutes of Health
Referans: RFA-HD-28-001
Destek listesi (ABD): 93.865 Child Health and Human Development Extramural Research
Son kontrol: 15 Kasım 2026

Resmi çağrıyı aç ↗

Resmi açıklamalar fon sağlayıcının dilindedir (çoğunlukla İngilizce); bu sayfadaki özet ve temel bilgiler Türkçedir.

Çağrı hakkında

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) seeks to establish a single Discovery Gateway to Reproductive Health Innovation, a comprehensive knowledgebase designed to advance research on male and female indications such as preeclampsia, endometriosis, preterm birth, infertility, and uterine fibroids. This initiative will expand shared resources and essential infrastructure for the biomedical research community.

The Gateway will facilitate integration of existing clinical, pharmacogenomic, and multi-omic data in order to address critical knowledge gaps. By providing open-access, this web-based visualization platform will empower scientists to generate new insights that extend far beyond the scope of individual research efforts. Ultimately, the overarching goal is to catalyze the discovery of new treatments and cures. By identifying potential disease mechanisms, effector genes, biomarkers, and drug targets, the Gateway will drive the development of innovative commercial products and accelerate public-private partnerships.

Tam metni oku

The Discovery Gateway supports multiple implementation recommendations made by the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC; https://www.nichd.nih.gov/about/advisory/PRGLAC ). Grant authorities that allow NICHD to forecast this opportunity are as follows: 42 U.S.C. 281 (Sec. 401); 42 U.S.C. 285g (Sec. 448); 42 USC 284h (Sec. 409D).

Kimler başvurabilir

Native American tribal governments (Federally recognized)
State governments
Special district governments
Private institutions of higher education
Independent school districts
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
For profit organizations other than small businesses
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Small businesses

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Konular

Health

Nasıl başvurulur

Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply: Not stated in the call text we hold — check the official page
Company stage: Not stated in the call text we hold — check the official page
Single applicant or consortium: Not stated in the call text we hold — check the official page
Where applicants must be based: Not stated in the call text we hold — check the official page
Where to apply: Not stated in the call text we hold — check the official page

İletişim

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB) · nichd_opptb_nofos@mail.nih.gov · Please contact via e-mail

Resmi kaynaklar

Resmi çağrı sayfası

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 15 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.